WHEN YOU RECEIVE YOUR CARD
If you’re eligible for the Savings Card, it will be issued to you when you enroll in Skyrizi Complete. Be sure to keep your card in a safe place since you’ll need it when scheduling your infusion appointments or when filling your SKYRIZI On-Body Injector prescription with your specialty pharmacy.
Your Savings Card can be used to cover eligible out-of-pocket costs wherever you receive your infusions, such as at your doctor’s office or infusion center.
Prescription rebates‡ may be an option
If your pharmacy is unable to process your Skyrizi Complete Savings Card for instant savings, you may still be able to get SKYRIZI for as little as $5 per treatment by using the Rebate Program. Just call 1.866.SKYRIZI (1.866.759.7494).
Skyrizi Complete offers 3 ways to submit your SKYRIZI prescription for a rebate:
An Insurance Specialist to help navigate
your unique situation
Specialist will help you review all coverage options, understand
details, and identify potential ways you may be able to save.
Skyrizi Complete Savings Card Terms & Conditions
Terms and Conditions apply. This benefit covers SKYRIZI® (risankizumab-rzaa) alone or for SKYRIZI with product associated infusion (maximum savings limit of $1,000 per year applies) and eligible liver enzyme and bilirubin lab monitoring costs (maximum savings limit of $1,000 per year applies) where the full cost is not covered by a patient’s insurance. Patient or healthcare provider is required to submit an Explanation of Benefits (EOB) following each infusion and/or laboratory test to the Co-Pay Program. Eligibility: Available to patients with commercial insurance coverage for SKYRIZI who meet eligibility criteria. Co-pay assistance program is not available to patients receiving reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the Skyrizi Complete Savings Card and patient must call Skyrizi Complete at 1.866.SKYRIZI to stop participation. Patients residing in or receiving treatment in certain states may not be eligible. Patients may not seek reimbursement for value received from the Skyrizi Complete program from any third-party payers. Offer subject to change or discontinuation without notice. Restrictions, including monthly maximums, may apply. Subject to all other terms and conditions, the maximum annual benefit that may be available solely for the patient’s benefit under the copay assistance program is $14,000 per calendar year. The actual application and use of the benefit available under the copay assistance program may vary on a monthly, quarterly, and/or annual basis depending on each individual patient’s plan of insurance and other prescription drug costs. With the exception of patients enrolled in a health plan subject to Maine insurance law, patients who are members of insurance plans that claim to reduce or eliminate their patients' out of pocket co-pay, coinsurance, or deductible obligations for certain prescription drugs based upon the availability of, or patient's enrollment in, manufacturer-sponsored co-pay assistance for such drugs (often termed "maximizer" programs) will have an annual maximum program benefit of up to $6,000.00 per calendar year. This assistance offer is not health insurance. By redeeming this card, you acknowledge that you are an eligible patient and that you understand and agree to comply with the terms and conditions of this offer. To learn about AbbVie’s privacy practices and your privacy choices, visit https://privacy.abbvie
Banking services provided by FLCBank, Member FDIC. The Skyrizi Complete Savings Mastercard is issued by FLCBank pursuant to a license Mastercard Inc. and may be used everywhere Mastercard cards are accepted.